IRIS PubliCatt

Scambia, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 30.165
EU - Europa 26.879
AS - Asia 11.126
AF - Africa 237
SA - Sud America 209
OC - Oceania 94
Continente sconosciuto - Info sul continente non disponibili 55
Totale 68.765
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 29.871
DE - Germania 6.004
SE - Svezia 5.978
CN - Cina 4.688
IT - Italia 4.634
SG - Singapore 3.284
IE - Irlanda 1.958
UA - Ucraina 1.946
FR - Francia 1.437
PL - Polonia 1.301
ID - Indonesia 1.244
GB - Regno Unito 903
FI - Finlandia 827
RU - Federazione Russa 816
IN - India 614
TR - Turchia 402
BE - Belgio 236
CA - Canada 219
IR - Iran 219
NL - Olanda 175
CI - Costa d'Avorio 153
HK - Hong Kong 148
JP - Giappone 119
BR - Brasile 102
ES - Italia 95
CZ - Repubblica Ceca 94
AU - Australia 77
CH - Svizzera 75
AT - Austria 73
RO - Romania 69
VN - Vietnam 67
KR - Corea 63
TW - Taiwan 44
MX - Messico 41
PH - Filippine 38
LT - Lituania 37
EU - Europa 33
CL - Cile 30
IL - Israele 30
PE - Perù 30
GR - Grecia 28
PT - Portogallo 27
EG - Egitto 25
BG - Bulgaria 24
BZ - Belize 23
HU - Ungheria 21
IQ - Iraq 19
MD - Moldavia 18
MY - Malesia 18
NO - Norvegia 18
AR - Argentina 17
HR - Croazia 17
NZ - Nuova Zelanda 17
DK - Danimarca 16
SA - Arabia Saudita 16
A2 - ???statistics.table.value.countryCode.A2??? 15
PK - Pakistan 15
ZA - Sudafrica 13
BD - Bangladesh 12
CO - Colombia 12
NG - Nigeria 12
AE - Emirati Arabi Uniti 10
DZ - Algeria 9
OM - Oman 9
RS - Serbia 9
SC - Seychelles 9
EC - Ecuador 8
A1 - Anonimo 7
LK - Sri Lanka 7
MT - Malta 7
EE - Estonia 6
KZ - Kazakistan 6
SK - Slovacchia (Repubblica Slovacca) 6
TH - Thailandia 6
UZ - Uzbekistan 6
LA - Repubblica Popolare Democratica del Laos 5
LU - Lussemburgo 5
MK - Macedonia 5
AM - Armenia 4
BH - Bahrain 4
CY - Cipro 4
KE - Kenya 4
MA - Marocco 4
GD - Grenada 3
GF - Guiana Francese 3
JO - Giordania 3
KG - Kirghizistan 3
LV - Lettonia 3
NP - Nepal 3
PA - Panama 3
QA - Qatar 3
VE - Venezuela 3
AZ - Azerbaigian 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
IS - Islanda 2
LI - Liechtenstein 2
MN - Mongolia 2
PY - Paraguay 2
Totale 68.740
Salva come PNG Salva come JPEG
Città #
Chandler 7.239
Singapore 2.584
Ashburn 2.562
Dublin 1.934
San Mateo 1.364
Jakarta 1.223
Jacksonville 1.218
Warsaw 1.206
New York 1.041
Wilmington 988
Nanjing 803
Ann Arbor 747
Boston 698
Milan 676
Rome 659
Fairfield 618
Princeton 610
Dearborn 601
Beijing 594
Moscow 536
Cattolica 532
Woodbridge 510
Houston 494
Marseille 493
Helsinki 384
Hangzhou 378
Seattle 363
Lawrence 356
Redwood City 338
Nürnberg 309
Bremen 294
Izmir 291
Nanchang 270
Los Angeles 255
Boardman 229
Munich 208
Brussels 207
Redmond 202
Cambridge 181
Mountain View 178
Chicago 176
Zhengzhou 161
Norwalk 155
Abidjan 153
Kunming 148
Leawood 140
Hebei 136
Shenyang 134
London 133
Lancaster 128
Guangzhou 122
University Park 119
Washington 118
Shanghai 116
Toronto 114
Changsha 112
Tianjin 112
Augusta 108
Pune 107
Jiaxing 96
Falkenstein 92
Hong Kong 92
Paris 78
Frankfurt am Main 76
Santa Clara 76
Busto Arsizio 75
Fremont 74
Andover 70
Hefei 68
Fuzhou 67
Naples 65
Falls Church 63
San Jose 62
Detroit 57
Jinan 57
Amsterdam 54
Kraków 54
Parma 50
San Francisco 50
Brno 48
Vienna 47
Nuremberg 46
Edinburgh 45
Phoenix 45
Oggiono 44
San Diego 44
Las Vegas 43
Lanzhou 41
Lappeenranta 40
Ottawa 40
Simi Valley 40
Kish 37
Palermo 37
Tokyo 35
Zurich 33
Buffalo 32
Ardabil 31
São Paulo 31
Wuhan 30
Changchun 29
Totale 39.059
Salva come PNG Salva come JPEG
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 797
The interpaly between immune system and microbiota in gynecological diseases : a narrative review. 526
The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer 452
Celiac disease and reproductive disorders: meta-analysis of epidemiologic associations and potential pathogenic mechanisms. 399
The chromosome analysis of the miscarriage tissue. Miscarried embryo/fetal crown rump length (CRL) measurement: A practical use 389
Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study 348
Synthetic PreImplantation Factor (PIF) prevents fetal loss by modulating LPS induced inflammatory response 328
Effect of Low Molecular Weight Heparins (LMWHs) on antiphospholipid Antibodies (aPL)-mediated inhibition of endometrial angiogenesis 318
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 311
Laparoendoscopic Single-Site Surgery (LESS) for Treatment of Benign Adnexal Disease: Single-Center Experience Over 3-Years 305
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial 303
Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence 253
Prognostic role of topoisomerase-IIalpha in advanced ovarian cancer patients 248
A randomized study comparing the use of the Ligaclip with bipolar energy to prevent lymphocele during laparoscopic pelvic lymphadenectomy for gynecologic cancer. 244
Elderly and very elderly advanced ovarian cancer patients: Does the age influence the surgical management? 237
Nutritional Interventions to Improve Clinical Outcomes in Ovarian Cancer: A Systematic Review of Randomized Controlled Trials. 234
A Novel Route of Transplantation of Human Cord Blood Stem Cells in Preimmune Fetal Sheep: The Intracelomic Cavity 201
La pandemia di COVID-19: un limite o una frontiera per la Legge 24/2017? 198
Evaluation of quality of life and emotional distress in endometrial cancer patients: A 2-year prospective, longitudinal study 187
Placental chemokine receptor D6 is functionally impaired in pre-eclampsia 184
I nuovi mezzi di contrasto nello studio delle patologie ginecologiche. Applicazioni diagnostiche e prospettive terapeutiche. 180
Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: long-term results 178
False-positive IgM for CMV in pregnant women with autoimmune disease: a novel prognostic factor for poor pregnancy outcome. 169
Transvaginal ultrasonography and magnetic resonance imaging for assessment of presence, size and extent of invasive cervical cancer. 168
Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery 167
A non-invasive prevention program model for the assessment of osteoporosis in the early postmenopausal period: a pilot study on FRAX(®) and QUS tools advantages 167
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 166
Laparoscopic staging of apparent early stage ovarian cancer: results of a large, retrospective, multi-institutional series 163
Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradiotherapy 149
Delaying surgery for patients with a previous SARS-CoV-2 infection 149
Adrenomedullin in Ovarian Cancer: Foe In Vitro and Friend In Vivo? 148
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 148
Perioperative morbidity and mortality in elderly gynecological oncological patients (>=70 years) by the American Society of Anaesthesiology physical status classes 146
Total laparoscopic hysterectomy in early-stage endometrial cancer using an intrauterine manipulator: is it a bias for frozen section analysis? Case-control study 145
Advanced vulvar carcinoma: is it worth operating? A perioperative management protocol for radical and reconstructive surgery 145
Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go 145
Predictors of pregnancy outcome in antiphospholipid syndrome: a review. 144
Human leukocyte antigen (HLA) DQ2/DQ8 prevalence in recurrent pregnancy loss women 143
Predictors of pregnancy outcome in antiphospholipid syndrome: a review 141
Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer. 141
Glucocorticoid therapy as a significant risk factor for osteoporosis and fractures in an Italian postmenopausal population. 141
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 138
Early detection of recurrence or progression disease in patients with ovarian cancer after primary debulking surgery: a diagnostic challenge still unresolved. Correlation between CT findings and CA 125 levels. 138
Valutazione comparativa dei costi di tre diverse modalità di trattamento dei fibromi uterini: embolizzazione, isterectomia e miomectomia 137
Thymopoiesis, regulatory T cells, and TCRVbeta expression in thymoma with and without myasthenia gravis, and modulatory effects of steroid therapy 137
A preliminary Quality Control (QC) for next generation sequencing (NGS) library evaluation turns out to be a very useful tool for a rapid detection of BRCA1/2 deleterious mutations 137
Radiologia Interventistica in ostetricia e ginecologia 136
Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery? 136
Urologic surgery in gynecologic oncology: a large single-institution experience 136
Femicide and murdered women's children: which future for these children orphans of a living parent? 135
Laparoscopic Nerve-Preserving Sacropexy 134
Abnormal uterine inflammation in obstetric syndromes: molecular insights into the role of chemokine decoy receptor D6 and inflammasome NLRP3. 134
Prognostic role of Ca125 response criteria and RECIST criteria: analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancer. 132
Sonographic imaging of urinoma 132
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 130
Laparoscopic, minilaparoscopic and single-port hysterectomy: perioperative outcomes 130
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience. 130
Succenturiate lobe of placenta with vessel anomaly: A case report of prenatal diagnosis and literature review 130
Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: A retrospective analysis 130
Non-hormonal treatment of vulvo-vaginal atrophy-related symptoms in post-menopausal women 130
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 129
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study 129
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 128
Influence of Intraperitoneal Dissemination Assessed by Laparoscopy on Prognosis of Advanced Ovarian Cancer: An Exploratory Analysis of a Single-Institution Experience 128
Embolizzazione delle arterie uterine 127
Is myomectomy always the best choice for infertile women with symptomatic uterine fibroids? 127
Trattamento non chirurgico dei fibromi uterini: l’embolizzazione arteriosa 125
Gli family transcription factors are drivers of patupilone resistance in ovarian cancer 125
Ovarian masses with papillary projections diagnosed and removed during pregnancy: ultrasound features and histological diagnoses 125
The sonographic prediction of invasive carcinoma in unilocular-solid ovarian cysts in premenopausal patients: a pilot study. 123
Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups 123
Patient-derived organoids and high grade serous ovarian cancer: from disease modeling to personalized medicine 123
The intracoelomic route: a new approach for in utero human cord blood stem cell transplantation. 122
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 122
A case of isolated ovarian recurrence from vulvar carcinoma. 121
Hyperprolactinemia: pathophysiology and therapeutic approach 120
Laparoscopic management of a large, twisted, ovarian dermoid cyst during pregnancy: a case report 119
Potential new mechanisms of placental damage in celiac disease: anti-transglutaminase antibodies impair human endometrial angiogenesis 118
Human IgG Antinuclear Antibodies Induce Pregnancy Loss in Mice by Increasing Immune Complex Deposition in Placental Tissue: In Vivo Study 118
Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome. 118
Selective arterial embolization as a first-line treatment for postpartum hematomas 117
Use of robot-specific resources and operating room times: the case of Telelap Alf-X robotic hysterectomy 117
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 116
A laparoscopic risk-adjusted model to predict major complications after primary debulking surgery in ovarian cancer: A single-institution assessment 116
Fetal cholelithiasis: a diagnostic update and a literature review 115
CDT reference values for monitoring chronic alcohol abuse in pregnancy 115
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 115
Improved binding of SARS-CoV-2 Envelope protein to tight junction-associated PALS1 could play a key role in COVID-19 pathogenesis 114
Color Doppler sonographic features of a Krukenberg tumor in pregnancy 113
Epidermal growth factor receptor in human breast cancer: correlation with steroid hormone receptors and axillary lymph node involvement 113
Phase 2 trial of nonpegylated doxorubicin (Myocet) as second-line treatment in advanced or recurrent endometrial cancer 113
Importance of a specialized pathologist for the examination of frozen sections of adnexal masses. 113
Imaging of gynecological disease: clinical and ultrasound characteristics of uterine sarcomas 112
Teaching and training in laparoscopic surgery: experience of Catholic Laparoscopy Advanced Surgery School in the basic gynecological surgery 110
Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix. 110
Adoptive immunotherapy with cytokine-induced killer cells generated with a new good manufacturing practice-grade protocol 110
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience 110
Incidence and risk factors for clinical failure of uterine leiomyoma embolization 109
Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study 109
Incidence and predictive factors for complications after uterine leiomyoma embolization 109
Totale 16.973
Salva come PNG Salva come JPEG
Categoria #
all - tutte 364.601
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 364.601
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.513 0 0 0 0 0 0 794 379 533 422 795 590
2020/20216.713 431 537 359 596 842 415 788 203 712 474 1.045 311
2021/20229.240 727 512 156 791 460 300 279 1.441 447 587 1.583 1.957
2022/202319.735 2.521 2.623 1.495 2.882 1.225 2.534 861 1.540 2.415 521 721 397
2023/202411.269 447 2.952 416 750 436 1.600 817 414 247 552 1.184 1.454
2024/20256.981 675 573 1.813 950 1.850 1.002 118 0 0 0 0 0
Totale 71.399